MASS Opportunities: A Biotechnology Investment Conference


	10.28.2002		10.29.2002

All times are Eastern Standard Time

9:30-9:50 3-D Matrix ARIAD Pharmaceuticals, Inc. Avoiding Arrest: Adventures in Cardiology

9:50-10:10 Acusphere, Inc. Alkermes, Inc.

10:10-10:30 Aderis Pharmaceuticals, Inc. Biogen, Inc.

10:30-10:50 Altus Biologics, Inc. AltaRex Corp.

10:50-11:10 AnVil, Inc. Antigenics, Inc. Corporate Governance: Mintz Levin Cohn Glovsky & Popeo PC

11:10-11:30 Archemix Corp. Acambis, Inc.

11:30-11:50 Bionaut Pharmaceuticals, Inc Arqule, Inc. TolerRx, Inc.

11:50-12:10 Bioplex Corp. Millenium Pharmaceuticals, Inc. Transform Pharmaceuticals, Inc.

12:10-1:10 LUNCH

1:10-1:30 BioProtein Technologies EXACT Sciences Corp. U.S. Genomics, Inc.

1:30-1:50 Cambria Biosciences EPIX Medical, Inc. UMASS Office of Tech Transfer

1:50-2:10 Cetek Corp. Genome Therapeutics Corp.

2:10-2:30 Coley Pharmaceuticals Group GPC Biotech AG Xerion Pharmaceuticals AG

2:30-2:40 BREAK

2:40-3:00 CombinatoRx, Inc. GTC Biotherapeutics, Inc. Proteomics: Bridging the Gap Between Genes & Therapeutics

3:00-3:20 Consensus Pharmaceuticals, Inc. Hybridon, Inc.

3:20-3:40 Control Delivery Systems, Inc. ImmunoGen, Inc.

3:40-4:00 Cyclis Pharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc.

4:00-4:20 Dynogen Pharmaceuticals, Inc. LION bioscience AG BioTrove, Inc.

4:20-4:40 DELEX Therapeutics, Inc. Lorus Therapeutics, Inc. Zycos, Inc.

4:40-5:00 Elixir Pharmaceuticals, Inc. Transkaryotic Therapies, Inc. Variagenics, Inc.

5:00-5:40 Beyond Borders: The Global Biotechnology Report 2002
ERNST & YOUNG